Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EPO Protein (AA 30-193) (Fc Tag)

EPO Origine: Humain Hôte: CHO Cells Recombinant >98 % (SDS-PAGE)
N° du produit ABIN6253353
  • Antigène Voir toutes EPO Protéines
    EPO (Erythropoietin (EPO))
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 30-193
    Origine
    • 14
    • 9
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Source
    • 19
    • 15
    • 7
    • 6
    • 3
    • 2
    • 1
    • 1
    • 1
    CHO Cells
    Purification/Conjugué
    Cette EPO protéine est marqué à la Fc Tag.
    Fonction
    EPO (human):Fc (human) (rec.) (non-lytic)
    Specificité
    The extracellular domain of human EPO (aa 30-193) is fused to the N-terminus of the Fc region of a mutant human IgG1.
    Attributs du produit
    Protein. The extracellular domain of human EPO (aa 30-193) is fused to the N-terminus of the Fc region of a mutant human IgG1. Source: CHO cells. Endotoxin content: <0.06EU/μg protein (LAL test, Lonza). Lyophilized from 0.2μm-filtered solution in PBS. Purity: >98 % (SDS-PAGE). Erythropoietin is the principal hormone involved in the regulation of erythropoiesis by stimulating the proliferation and differentiation of erythroid progenitor cells and the maintenance of a physiological level of circulating erythrocyte mass. It is a glycoprotein produced primarily by the kidney. The biological effects of EPO are mediated by the erythropoietin receptor (Epo R). Genetic variations in EPO is associated with susceptibility to microvascular complications of diabetes type 2 (MVCD2) (including diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease and diabetic neuropathy). It is used for the treatment of anemia and misused as a performance-enhancing drug in endurance athletes.
    Pureté
    >98 % (SDS-PAGE)
    niveau d'endotoxine
    <0.06EU/μg protein (LAL test, Lonza).
    Biological Activity Comment
    Measured by the dose-dependant stimulation of human megakaryoblastic leukemia cells.
    Top Product
    Discover our top product EPO Protéine
  • Restrictions
    For Research Use only
  • Format
    Lyophilized
    Concentration
    Lot specific
    Buffer
    Lyophilized from 0.2μm-filtered solution in PBS.
    Conseil sur la manipulation
    Avoid freeze/thaw cycles.
    Stock
    4 °C,-20 °C
    Stockage commentaire

    Short Term Storage: +4°C

    Long Term Storage: -20°C

    Use & Stability: Stable for at least 1 year after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C.

  • Antigène
    EPO (Erythropoietin (EPO))
    Autre désignation
    EPO (EPO Produits)
    Synonymes
    EPO Protein, EP Protein, MVCD2 Protein, erythropoietin Protein, erythropoietin S homeolog Protein, erythropoietin a Protein, EPO Protein, epo Protein, epo.S Protein, Epo Protein, epoa Protein
    Classe de substances
    Hormone
    Sujet

    Alternate Names/Synonyms: Erythropoietin, Epoetin

    Product Description: Erythropoietin is the principal hormone involved in the regulation of erythropoiesis by stimulating the proliferation and differentiation of erythroid progenitor cells and the maintenance of a physiological level of circulating erythrocyte mass. It is a glycoprotein produced primarily by the kidney. The biological effects of EPO are mediated by the erythropoietin receptor (Epo R). Genetic variations in EPO is associated with susceptibility to microvascular complications of diabetes type 2 (MVCD2) (including diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease and diabetic neuropathy). It is used for the treatment of anemia and misused as a performance-enhancing drug in endurance athletes.

    NCBI Accession
    NP_000790
    Pathways
    Signalistation JAK/STAT, Hormone Activity, Negative Regulation of intrinsic apoptotic Signaling, Negative Regulation of Transporter Activity
Vous êtes ici:
Support technique